Stock listing

Pharming Group Nv

Selected listing: PHARM · EURONEXT · EUR · NL

Pharming Group Nv (Euronext:PHARM), Health Technology. Latest release Sep 29, 2026: Pharming announces CEO transition.

PHARM:EURONEXTEURNLUpdated October 3, 2026

Ticker: Euronext:PHARM
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Euronext
Currency: EUR

About Pharming Group Nv

Pharming Group NV is a public company listed under the ticker PHARM on the Netherlands stock market. Pharming focuses on developing innovative therapies for rare diseases, leveraging advanced biotechnology to improve patient outcomes.

Latest news from Pharming Group Nv

Pharming announces CEO transition

September 29, 2026

Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS

September 25, 2026

Pharming announces positive Phase II topline data for leniolisib in PIDs with immune dysregulation accepted as late-breaking abstract at ESID 2026

September 22, 2026

FDA approves Pharming's Joenja(R) as first treatment for children with APDS in the U.S.

September 14, 2026

FDA approves Pharming’s Joenja® as first treatment for children with APDS in the U.S.

September 11, 2026

All Pharming Group Nv news →

Events

Replays

Pharming Group N.V. (PHAR) Q2 2026 Earnings Call
Thu, Jul 30, 2026 · 07:30 AM ET
Watch
Pharming Group N.V. (PHAR) Q1 2026 Earnings Call
Thu, May 07, 2026 · 07:30 AM ET
Watch
Pharming Group N.V. (PHAR) Q4 2025 Earnings Call
Thu, Mar 12, 2026 · 08:30 AM ET
Watch

Research Pharming Group Nv

Pharming Group Nv company profile

View the public company page for Pharming Group Nv on 6ix.

Pharming Group Nv news

Read company news and market updates connected to Pharming Group Nv.

Pharming Group Nv investor events

Find investor webinars, events, and replay context for Pharming Group Nv.